Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
MEI Pharma, Inc. (MEIP)
|
Add to portfolio |
|
|
|
| Price: |
$3.55
| | Metrics |
| OS: |
6.66
|
M
| |
-129
|
% ROE
|
| Market cap: |
$23.7
|
M
| |
-44
|
% ROIC
|
|
Net cash:
|
$16.9
|
M
| |
$2.54
|
per share
|
|
EV:
|
$6.75
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($36.4)
|
M
| |
|
|
|
EBIT
|
($36.8)
|
M
| |
|
|
| EPS |
($3.87)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
| Revenues | 48.8 | 40.7 | 34.8 | 27.8 | 4.9 | 1.6 | 23.2 | 0.0 |
| Revenue growth | 19.9% | 17.0% | 25.4% | 464.7% | 203.0% | -93.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 1.4 | 2.7 | 4.3 | 3.4 | 5.0 | 0.0 |
| Gross profit | 48.8 | 40.7 | 33.4 | 25.1 | 0.7 | -1.8 | 18.2 | 0.0 |
| Gross margin | 100.0% | 100.0% | 96.0% | 90.4% | 13.3% | -108.6% | 78.5% | |
| Selling, general and administrative | | | | | | | | |
| Research and development | 52.5 | 85.6 | 69.4 | 34.1 | 32.3 | 17.0 | 7.2 | 13.4 |
| General and administrative | 33.1 | 30.5 | 24.4 | 16.7 | 14.6 | 9.8 | 8.6 | 7.6 |
| EBITA | -36.8 | -75.5 | -60.4 | -25.7 | -11.2 | -28.6 | 2.4 | -21.0 |
| EBITA margin | -75.3% | -185.5% | -173.7% | -92.6% | -228.8% | -1760.2% | 10.4% | |
| Amortization of intangibles | | | | | 35.0 | 0.0 | 0.0 | 0.0 |
| EBIT | -36.8 | -75.5 | -60.4 | -25.7 | -46.2 | -28.6 | 2.4 | -21.0 |
| EBIT margin | -75.3% | -185.5% | -173.7% | -92.6% | -940.9% | -1762.4% | 10.3% | |
| Pre-tax income | -31.8 | -54.5 | -41.3 | -47.2 | -16.8 | -40.1 | 2.7 | -20.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | | | 0.0% | 0.0% | | 0.0% |
| Net income | -31.8 | -62.5 | -68.7 | -47.2 | -54.6 | -40.1 | 2.7 | -20.9 |
| Net margin | -65.2% | -153.6% | -197.5% | -170.0% | -1111.1% | -2470.3% | 11.5% | |
| |
| Diluted EPS | ($4.78) | ($9.99) | ($0.60) | ($0.52) | ($0.75) | ($0.97) | $0.07 | ($0.61) |
| Shares outstanding (diluted) | 6.7 | 6.3 | 114.5 | 91.1 | 72.4 | 41.4 | 36.9 | 34.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|